Revenue: As of FY2025 Q1, the actual value is USD 386.86 M.EPS: As of FY2025 Q1, the actual value is USD -0.04.<h3>Medical Office and Life Science Portfolio</h3><ul><li>Revenues: $49,763 for the three months ended March 31, 2025, compared to $54,149 for the same period in 2024.</li><li>Net Operating Income (NOI): $26,856 for the three months ended March 31, 2025, compared to $30,252 for the same period in 2024, reflecting an 11.2% decrease.</li><li>Occupancy: 80.6% as of March 31, 2025, compared to 82.9% as of March 31, 2024.</li></ul><h3>SHOP (Senior Housing Operating Portfolio)</h3><ul><li>Revenues: $328,306 for the three months ended March 31, 2025, compared to $308,126 for the same period in 2024.</li><li>Net Operating Income (NOI): $36,828 for the three months ended March 31, 2025, compared to $24,710 for the same period in 2024, reflecting a 49.0% increase.</li><li>Occupancy: 80.2% as of March 31, 2025, compared to 78.9% as of March 31, 2024.</li></ul><h3>All Other</h3><ul><li>Revenues: $8,795 for the three months ended March 31, 2025, compared to $8,501 for the same period in 2024.</li><li>Net Operating Income (NOI): $8,854 for the three months ended March 31, 2025, compared to $8,210 for the same period in 2024, reflecting a 7.8% increase.</li></ul><h3>Cash Flow</h3><ul><li>Net cash used in operating activities: -$3,243 for the three months ended March 31, 2025, compared to $28,602 provided in the same period in 2024.</li><li>Net cash provided by investing activities: $291,093 for the three months ended March 31, 2025, compared to -$58,839 used in the same period in 2024.</li><li>Net cash used in financing activities: -$131,049 for the three months ended March 31, 2025, compared to -$8,561 used in the same period in 2024.</li></ul><h3>Future Outlook</h3><ul><li>The company expects favorable supply and demand dynamics in the senior living industry to enable managers to continue growing occupancy and driving positive performance. While certain costs, primarily labor, insurance, and food costs, have increased, these cost increases are expected to moderate, providing managers the opportunity to increase rates in excess of cost increases, resulting in improving returns.</li></ul>

Diversified Healthcare Pref Share DHCNI 5.625 08/01/42 | 10-Q: FY2025 Q1 Revenue: USD 386.86 M